3-189886371-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003722.5(TP63):c.1350-23T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.766 in 1,611,378 control chromosomes in the GnomAD database, including 475,797 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.74 ( 42417 hom., cov: 32)
Exomes 𝑓: 0.77 ( 433380 hom. )
Consequence
TP63
NM_003722.5 intron
NM_003722.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0850
Publications
17 publications found
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
- ADULT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ankyloblepharon-ectodermal defects-cleft lip/palate syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- limb-mammary syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Rapp-Hodgkin syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- premature ovarian failure 21Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- split hand-foot malformation 4Inheritance: AD Classification: MODERATE Submitted by: Illumina
- EEC syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- split hand-foot malformationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 3-189886371-T-C is Benign according to our data. Variant chr3-189886371-T-C is described in ClinVar as Benign. ClinVar VariationId is 259127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.783 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.744 AC: 113060AN: 151954Hom.: 42399 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
113060
AN:
151954
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.711 AC: 178228AN: 250778 AF XY: 0.723 show subpopulations
GnomAD2 exomes
AF:
AC:
178228
AN:
250778
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.768 AC: 1120877AN: 1459304Hom.: 433380 Cov.: 41 AF XY: 0.768 AC XY: 557986AN XY: 726078 show subpopulations
GnomAD4 exome
AF:
AC:
1120877
AN:
1459304
Hom.:
Cov.:
41
AF XY:
AC XY:
557986
AN XY:
726078
show subpopulations
African (AFR)
AF:
AC:
24883
AN:
33438
American (AMR)
AF:
AC:
22971
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
AC:
17837
AN:
26116
East Asian (EAS)
AF:
AC:
25197
AN:
39654
South Asian (SAS)
AF:
AC:
61850
AN:
86134
European-Finnish (FIN)
AF:
AC:
37249
AN:
52984
Middle Eastern (MID)
AF:
AC:
4880
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
880050
AN:
1110190
Other (OTH)
AF:
AC:
45960
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
12819
25637
38456
51274
64093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20554
41108
61662
82216
102770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.744 AC: 113118AN: 152074Hom.: 42417 Cov.: 32 AF XY: 0.735 AC XY: 54599AN XY: 74318 show subpopulations
GnomAD4 genome
AF:
AC:
113118
AN:
152074
Hom.:
Cov.:
32
AF XY:
AC XY:
54599
AN XY:
74318
show subpopulations
African (AFR)
AF:
AC:
31014
AN:
41482
American (AMR)
AF:
AC:
9505
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
2401
AN:
3470
East Asian (EAS)
AF:
AC:
3128
AN:
5164
South Asian (SAS)
AF:
AC:
3445
AN:
4822
European-Finnish (FIN)
AF:
AC:
7444
AN:
10580
Middle Eastern (MID)
AF:
AC:
263
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53627
AN:
67974
Other (OTH)
AF:
AC:
1602
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1491
2982
4473
5964
7455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2283
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.